Willem E. Fibbe

27.4k total citations · 10 hit papers
215 papers, 19.4k citations indexed

About

Willem E. Fibbe is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Willem E. Fibbe has authored 215 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Hematology, 91 papers in Genetics and 72 papers in Immunology. Recurrent topics in Willem E. Fibbe's work include Mesenchymal stem cell research (82 papers), Hematopoietic Stem Cell Transplantation (80 papers) and Immune Cell Function and Interaction (24 papers). Willem E. Fibbe is often cited by papers focused on Mesenchymal stem cell research (82 papers), Hematopoietic Stem Cell Transplantation (80 papers) and Immune Cell Function and Interaction (24 papers). Willem E. Fibbe collaborates with scholars based in Netherlands, Italy and United States. Willem E. Fibbe's co-authors include Alma J. Nauta, Maria Ester Bernardo, Helene Roelofs, Roel Willemze, Franco Locatelli, Sicco A. Scherjon, Alwine B. Kruisselbrink, Frans H.J. Claas, Ellie G.A. Lurvink and Humphrey H.H. Kanhai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Willem E. Fibbe

212 papers receiving 18.9k citations

Hit Papers

Mesenchymal stem cells for treatment of steroid-resis... 1997 2026 2006 2016 2008 2007 2013 2004 1997 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
    2008 2.0k citations Helene Roelofs, Maria Ester Bernardo et al. profile →
  2. Immunomodulatory properties of mesenchymal stromal cells
    2007 1.4k citations Alma J. Nauta, Willem E. Fibbe Blood profile →
  3. Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
    2013 1.1k citations Maria Ester Bernardo, Willem E. Fibbe profile →
  4. Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta
    2004 922 citations Frans H.J. Claas, Willem E. Fibbe et al. Stem Cells profile →
  5. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
    1997 771 citations Alfred H. Schinkel, Ulrich Mayer et al. Proceedings of the National Academy of Sciences profile →
  6. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation
    2003 590 citations Frans H.J. Claas, R. Willemze et al. Blood profile →
  7. Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells
    2006 569 citations Alma J. Nauta, Alwine B. Kruisselbrink et al. The Journal of Immunology profile →
  8. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
    2006 545 citations Alma J. Nauta, Geert Westerhuis et al. Blood profile →
  9. Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells
    2008 542 citations Willem E. Fibbe, Hergen Spits et al. profile →
  10. Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts
    2013 339 citations Jaap Jan Zwaginga, Willem E. Fibbe et al. profile →

Peers

Willem E. Fibbe
Edwin M. Horwitz United States
Diane S. Krause United States
Christian Jørgensen France
Jacques Galipeau United States
Berit Sundberg Sweden
Bruno Péault United States
Mervin C. Yöder United States
Zhongchao Han China
Francesco Frassoni Italy
Mark A. Moorman United States
Edwin M. Horwitz United States
Willem E. Fibbe
Citations per year, relative to Willem E. Fibbe Willem E. Fibbe (= 1×) peers Edwin M. Horwitz

Countries citing papers authored by Willem E. Fibbe

Since Specialization
Citations

This map shows the geographic impact of Willem E. Fibbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem E. Fibbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem E. Fibbe more than expected).

Fields of papers citing papers by Willem E. Fibbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willem E. Fibbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem E. Fibbe. The network helps show where Willem E. Fibbe may publish in the future.

Co-authorship network of co-authors of Willem E. Fibbe

This figure shows the co-authorship network connecting the top 25 collaborators of Willem E. Fibbe. A scholar is included among the top collaborators of Willem E. Fibbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willem E. Fibbe. Willem E. Fibbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halteren, Astrid G. S. van, Sandra Laban, Roula Tsonaka, et al.. (2022). A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease. Blood. 141(11). 1277–1292. 2 indexed citations
2.
Reinders, Marlies E. J., Sanne H. Hendriks, Aiko P. J. de Vries, et al.. (2021). Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study. American Journal of Transplantation. 21(9). 3055–3065. 30 indexed citations
3.
Heidt, Sebastiaan, Dave L. Roelen, Melissa van Pel, et al.. (2020). Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study. American Journal of Transplantation. 20(10). 2905–2915. 34 indexed citations
4.
Staal, Frank J. T., Herman P. Spaink, & Willem E. Fibbe. (2015). Visualizing Human Hematopoietic Stem Cell Trafficking In Vivo Using a Zebrafish Xenograft Model. Stem Cells and Development. 25(4). 360–365. 24 indexed citations
5.
Bernardo, Maria Ester & Willem E. Fibbe. (2015). Mesenchymal stromal cells and hematopoietic stem cell transplantation. Immunology Letters. 168(2). 215–221. 49 indexed citations
6.
Ramshorst, Jan van, Saskia L.M.A. Beeres, Petra Dibbets‐Schneider, et al.. (2011). Intramyocardial Injection of Bone Marrow Mononuclear Cells in Patients with Chronic Myocardial Ischemia: an Intra-Patient Comparison. Circulation. 124(21). 2 indexed citations
7.
Ramshorst, Jan van, Saskia L.M.A. Beeres, Petra Dibbets‐Schneider, et al.. (2011). Intramyocardial Bone Marrow Cell Injection in Patients with Chronic Myocardial Ischemia : Results Long Term Follow-Up. Circulation. 124(21). 1 indexed citations
8.
Ramshorst, Jan van, Saskia L.M.A. Beeres, Petra Dibbets‐Schneider, et al.. (2011). Abstract 15218: Intramyocardial Injection of Bone Marrow Mononuclear Cells in Patients with Chronic Myocardial Ischemia: an Intra-Patient Comparison. Circulation. 124. 1 indexed citations
9.
Duijvestein, Marjolijn, Ilse Molendijk, Helene Roelofs, et al.. (2011). Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy. 13(9). 1066–1073. 40 indexed citations
10.
Nauta, Alma J., Geert Westerhuis, Alwine B. Kruisselbrink, et al.. (2006). Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood. 108(6). 2114–2120. 545 indexed citations breakdown →
11.
Nauta, Alma J., Alwine B. Kruisselbrink, Ellie G.A. Lurvink, Roel Willemze, & Willem E. Fibbe. (2006). Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells. The Journal of Immunology. 177(4). 2080–2087. 569 indexed citations breakdown →
12.
Ball, L.M., Arjan C. Lankester, Robbert G. M. Bredius, et al.. (2005). Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplantation. 35(S1). S35–S38. 30 indexed citations
13.
Velders, Gerjo A., Ronald van Os, H. F. L. Guiot, et al.. (2003). Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood. 103(1). 340–346. 43 indexed citations
14.
Os, Ronald van, Marianke L.J. van Schie, R. Willemze, & Willem E. Fibbe. (2002). Proteolytic Enzyme Levels Are Increased During Granulocyte Colony-Stimulating Factor-Induced Hematopoietic Stem Cell Mobilization in Human Donors but Do Not Predict the Number of Mobilized Stem Cells. Journal of Hematotherapy & Stem Cell Research. 11(3). 513–521. 20 indexed citations
15.
Pruijt, Hans, Yvette van Kooyk, Carl G. Figdor, Roel Willemze, & Willem E. Fibbe. (1999). Murine Hematopoietic Progenitor Cells With Colony-Forming or Radioprotective Capacity Lack Expression of the β2-Integrin LFA-1. Blood. 93(1). 107–112. 27 indexed citations
16.
Schinkel, Alfred H., Ulrich Mayer, Els Wagenaar, et al.. (1997). Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proceedings of the National Academy of Sciences. 94(8). 4028–4033. 771 indexed citations breakdown →
17.
Fibbe, Willem E., J. M. J. M. Zijlmans, & Roel Willemze. (1997). Differential short‐term and long‐term repopulating ability of stem cell subsets in mice. Stem Cells. 15(S2). 47–53. 7 indexed citations
18.
Goselink, Henriëtte M., Jo Van Damme, Pieter S. Hiemstra, et al.. (1996). Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase.. The Journal of Experimental Medicine. 184(4). 1305–1312. 15 indexed citations
19.
Willemze, R., Willem E. Fibbe, JH Falkenburg, et al.. (1993). Biology and treatment of myelodysplastic syndromes — developments in the past decade. Annals of Hematology. 66(3). 107–115. 21 indexed citations
20.
Gratama, Jan W., M. A. P. Oosterveer, Willem E. Fibbe, et al.. (1992). Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists. Annals of Hematology. 64(S1). A162–A165. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edwin M. Horwitz Breakdown of academic impact, for papers by Diane S. Krause Breakdown of academic impact, for papers by Christian Jørgensen Breakdown of academic impact, for papers by Jacques Galipeau Breakdown of academic impact, for papers by Berit Sundberg Breakdown of academic impact, for papers by Bruno Péault Breakdown of academic impact, for papers by Mervin C. Yöder Breakdown of academic impact, for papers by Zhongchao Han Breakdown of academic impact, for papers by Francesco Frassoni Breakdown of academic impact, for papers by Mark A. Moorman
Rankless by CCL
2026